HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination
Eliminating hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) remains a major challenge, requiring innovative treatment strategies and drug candidates. Clinical studies reveal that wild-type HBV in the blood is often replaced by gradually rising mutant populations. This replacement ref...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2025-12-01
|
| Edice: | Molecular Therapy: Methods & Clinical Development |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2329050125002414 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|